RESTON, Va., May 1, 2007 (PRIME NEWSWIRE) -- TenthGate International, Inc. (Pink Sheets:TGTI) ("TenthGate") www.TenthGate.biz announced today the sale of 5,000 SutureMate(r) safety devices to DeRoyal Medical ("DeRoyal"). DeRoyal finishes and sells SutureMate through their sales representatives located nationwide under their "Surgi-Mate" safety product line (www.deroyal.com). This represents TenthGate's initial revenues since acquiring TenthGate Incorporated and its subsidiaries in March of this year.
SutureMate is currently used in operating rooms, emergency rooms, surgical centers and medical providers' offices as a specifically engineered safety product to help prevent needle sticks before, during and after a suturing procedure by:
1. Protecting the suture needle tips during preparation of the procedure
2. Allowing safe parking of the suture needle in between stitches
3. Providing a protected knife blade for easy needle removal prior to knot typing
4. Holding the used suture needle and protecting the tip prior to movement to the needle counter.
Tim Novak, CEO of TenthGate commented, "The Occupational Safety and Health Administration require that specifically engineered safety devices be in place to help prevent needle sticks in healthcare delivery settings. The SutureMate product helps healthcare providers protect themselves from unnecessary needle stick exposures and offers healthcare facilities a simple, low cost method to comply with current industry safety requirements."
About Needle Sticks: http://www.osha.gov/needlesticks/needlefaq.html
About SutureMate: http://www.tenthgate.biz/healthSafety.html
About TenthGate:
TenthGate International, Inc. is a Delaware corporation focused on the acquisition and development of life changing, health related technologies. The range of acquired technologies includes biotech/life sciences, diagnostic tools, innovative medical and provider safety devices. TenthGate has acquired several intellectual properties and licenses to date, two of which have obtained FDA approval. The company has obtained worldwide exclusive license for an emerging melanoma diagnostic and prevention technology utilizing Electron Paramagnetic Resonance (EPR).
The TenthGate International, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3179
Safe Harbor Disclaimer
Except for the historical information contained herein, the matters discussed in this press release may include forward-looking statements or information. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of TenthGate International, Inc., and its affiliates, set forth herein and those preceded by or that include the words "believes," "expects," "given," "targets," "intends," "anticipates," "plans," "projects", "forecasts" or similar expressions, are forward-looking statements. Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties which could cause the Company's future results to differ materially from those anticipated. Other risks are detailed from time to time in the Company's Annual and Quarterly Reports and in its other Securities and Exchange Commission reports and statements. The Company assumes no obligation to update any of the information contained or referenced in this press release.